起帆電纜(605222.SH)擬發行10億元可轉債 初始轉股價20.53元/股
格隆匯5月19日丨起帆電纜(605222.SH)公佈,公司公開發行可轉換公司債券已獲得中國證券監督管理委員會“證監許可[2021]667號”文核准。本次共發行10億元可轉債,每張面值為人民幣100元,共計1000萬張(100萬手),按面值發行。可轉債簡稱為“起帆轉債”,債券代碼為“111000”。初始轉股價格為20.53元/股,本次發行的原股東優先配售日和網上申購日為2021年5月24日(T日)。
發行人本次募集資金將投資於“池州起帆電線電纜產業園建設項目”和“補充流動資金”。網上路演時間2021年5月21日(週五)10:00-12:00。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.